Literature DB >> 28082147

Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy.

Thomas Klag1, Julia Dietz2, Christoph R Werner1, Julia M Schwarz1, Ulrich M Lauer1, Robert Beck3, Nisar P Malek1, Christoph Sarrazin2, Christoph P Berg4.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28082147     DOI： 10.1016/j.jhep.2017.01.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Care of Patients Following Cure of Hepatitis C Virus Infection.

Authors:  Norah A Terrault
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-11

2.  HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals.

Authors:  Viola Guardigni; Valeria Cento; Stefano Ianniruberto; Lorenzo Badia; Marianna Aragri; Matteo Conti; Carlo Federico Perno; Pierluigi Viale; Francesca Ceccherini-Silberstein; Gabriella Verucchi
Journal:  Infection       Date:  2018-05-26       Impact factor: 3.553

3.  Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.

Authors:  Ken Kurokawa; Takamasa Ohki; Jun Kato; Yukiyo Fukumura; Makoto Imai; Chikako Shibata; Junya Arai; Mayuko Kondo; Kaoru Takagi; Kentaro Kojima; Michiharu Seki; Masaya Mori; Nobuo Toda; Kazumi Tagawa
Journal:  J Med Case Rep       Date:  2020-05-27

4.  Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt.

Authors:  Ahmed Nagaty; Ekram W Abd El-Wahab
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.